Dronedarone for early atrial fibrillation
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether the medication dronedarone can help people with early atrial fibrillation (an irregular heartbeat) get back to a normal rhythm. It may help reduce symptoms and improve long-term heart health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years or older.
- You must have been diagnosed with atrial fibrillation within the past year.
- You must have a life expectancy of at least one year.
- You must be considered a good candidate for a rhythm-control medication such as dronedarone or a class Ic drug.
- You cannot have permanent (constant) atrial fibrillation.
- You cannot have severe structural heart disease or severe kidney or liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether starting treatment early to control your heart's rhythm can help people with a heart device who have short bursts of a fast heartbeat (called atrial high rate episodes) but haven't yet been diagnosed with atrial fibrillation on a standard EKG or Holter monitor.
This study compares different heart rate targets for people with ongoing atrial fibrillation (an irregular heartbeat) to find which one improves symptoms and quality of life. It may help you and your doctor choose the best treatment plan.
This study tests a new medicine, budiodarone, to help control atrial fibrillation (an irregular heartbeat) in people who haven't been helped by other treatments. It may reduce the time spent in AF and improve symptoms.
This study tests whether giving the medicine amiodarone before a scheduled electrical cardioversion (a procedure that shocks the heart back into rhythm) improves the chances of restoring a normal heartbeat in people with persistent atrial fibrillation. It compares outcomes with and without this pre-treatment.
This trial tests a heart rhythm drug called flecainide to see if it is safe for people who have both atrial fibrillation (an irregular heartbeat) and coronary artery disease (narrowed heart blood vessels). Participation could help doctors decide if this drug is a good treatment option for you.
This study tests whether a daily medication called dapagliflozin (usually used for diabetes) can improve the success of rhythm control (treatments that bring your heartbeat back to normal) in people with recent atrial fibrillation. If you join, you would receive either the study drug or a placebo along with standard care.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.